INTERIM CONSOLIDATED FINANCIAL STATEMENTS STATEMENTS OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flow from operating activities:
Net income (loss)	$ (252)	$ 5,568
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	34,580	32,970
Amortization of above and below market leases	139	259
Amortization of deferred loan costs	962	872
Amortization of senior notes discount		68
Equity-based compensation expense	3,481	3,082
Bad debt expense (recoveries)	(863)	314
Deferred tax benefit	(2,402)	(1,581)
Restructuring costs, net of cash paid	8,020
Changes in operating assets and liabilities
Rents and other receivables, net	2,753	(1,084)
Prepaid expenses	(4,165)	(3,253)
Other assets	(3,339)	(800)
Accounts payable and accrued liabilities	9,619	(11,815)
Advance rents, security deposits and other liabilities	(354)	4,144
Deferred income	3,374	1,791
Net cash provided by operating activities	51,553	30,535
Cash flow from investing activities:
Acquisitions, net of cash acquired	(24,626)
Additions to property and equipment	(103,936)	(66,119)
Net cash used in investing activities	(128,562)	(66,119)
Cash flow from financing activities:
Credit facility proceeds	102,000	67,000
Credit facility repayments	(95,000)
Debt proceeds		1,920
Payment of deferred financing costs	(499)	(4)
Payment of dividends	(19,670)	(17,222)
Distribution to noncontrolling interests	(2,552)	(2,442)
Proceeds from exercise of stock options		42
Payment of tax withholdings related to equity based awards	(867)	(1,770)
Principal payments on capital lease obligations	(2,324)	(3,249)
Mortgage principal debt repayments	(16)	(14)
Preferred Stock issuance proceeds, net of costs	103,615
Net cash provided by financing activities	84,687	44,261
Net increase in cash and cash equivalents	7,678	8,677
Cash and cash equivalents, beginning of period	8,243	9,580
Cash and cash equivalents, end of period	15,921	18,257
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest (excluding deferred financing costs and amounts capitalized)	4,720	9,368
Noncash investing and financing activities:
Accrued capital additions	102,489	39,673
Increase in other assets related to change in fair value of interest rate swaps	5,982
Accrued equity issuance costs	432
Accrued preferred stock dividend	328
Qualitytech, LP
Cash flow from operating activities:
Net income (loss)	(252)	5,568
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	34,580	32,970
Amortization of above and below market leases	139	259
Amortization of deferred loan costs	962	872
Amortization of senior notes discount		68
Equity-based compensation expense	3,481	3,082
Bad debt expense (recoveries)	(863)	314
Deferred tax benefit	(2,402)	(1,581)
Restructuring costs, net of cash paid	8,020
Changes in operating assets and liabilities
Rents and other receivables, net	2,753	(1,084)
Prepaid expenses	(4,165)	(3,253)
Other assets	(3,339)	(800)
Accounts payable and accrued liabilities	9,619	(11,815)
Advance rents, security deposits and other liabilities	(354)	4,144
Deferred income	3,374	1,791
Net cash provided by operating activities	51,553	30,535
Cash flow from investing activities:
Acquisitions, net of cash acquired	(24,626)
Additions to property and equipment	(103,936)	(66,119)
Net cash used in investing activities	(128,562)	(66,119)
Cash flow from financing activities:
Credit facility proceeds	102,000	67,000
Credit facility repayments	(95,000)
Debt proceeds		1,920
Payment of deferred financing costs	(499)	(4)
Payment of dividends	(19,670)	(17,222)
Partnership distributions	(2,552)	(2,442)
Proceeds from exercise of stock options		42
Payment of tax withholdings related to equity based awards	(867)	(1,770)
Principal payments on capital lease obligations	(2,324)	(3,249)
Mortgage principal debt repayments	(16)	(14)
Preferred Stock issuance proceeds, net of costs	103,615
Net cash provided by financing activities	84,687	44,261
Net increase in cash and cash equivalents	7,678	8,677
Cash and cash equivalents, beginning of period	8,243	9,580
Cash and cash equivalents, end of period	15,921	18,257
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest (excluding deferred financing costs and amounts capitalized)	4,720	9,368
Noncash investing and financing activities:
Accrued capital additions	102,489	$ 39,673
Increase in other assets related to change in fair value of interest rate swaps	5,982
Accrued equity issuance costs	432
Accrued preferred stock dividend	$ 328